Metabolic Syndrome Clinical Trial
Official title:
Randomized Controlled Trial of a Water Beverage Intervention Trial for Reducing Risk Factors of Metabolic Syndrome in Young Mexican Free Living Women
Research Question: Does replacing Sugar Sweetened (SS) beverages with water consumption
promote a decrease in triglycerides blood levels over 9 months in overweight women? The
primary outcome variable is the triglycerides blood level. In addition, the investigators
will consider as secondary outcome variables the following parameters of metabolic syndrome:
weight, fasting insulin and glucose, HOMA, HDL-cholesterol, systolic and diastolic blood
pressure, and waist circumference. The investigators will also consider as an outcome
variable glycosylated (or glycated) hemoglobin (HbA1c).
Design: Two groups randomized controlled trial, with an intervention group (water and
education provision) and control group (education provision only).
The investigators propose to recruit young adult women aged >18-<45 y who are overweight or
obese (BMI >25 and <39), and consume at least 250 calories per day from caloric beverages
(e.g., includes soft drinks, juices, sports drinks, sweetened tea or coffee, and alcoholic
beverages) The intervention group (water and education provision) will be compared with a
control condition (education provision only). The intervention has been proposed to be
carried out for 9 months period with objective measurements of body weight and fat, total
cholesterol, LDL-C, HDL-C, fasting blood glucose, HbA1C, hydration status, blood pressure,
and 24 hrs dietary recalls at baseline, 3,6 and 9 months
Status | Completed |
Enrollment | 240 |
Est. completion date | August 2011 |
Est. primary completion date | August 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: - Young adult women aged >18-<45 y - BMI >25 and <39 - Consume at least 250 calories per day from caloric beverage - Women planning to live in the study area over the next year - Willingness to participate in the required evaluations - Women have given their consent to participate Exclusion Criteria: - Report losing >5% of current body weight in the previous 6 months. Individuals who have recently lost significant body weight may be at high risk for weight regain, which could result in this study examining prevention of weight regain rather than weight loss. - If they report to be on a diet to reduce weight at the time of recruitment - Report pregnancy during the previous 6 months or if they are lactating at the time of recruitment or they are planning to become pregnant in the following 12 months. - Report current treatment for any medical condition that could impact metabolic function (e.g.., diabetes mellitus, cancer, Etc.). - History of myocardial infarction or heart surgery such as bypass or angioplasty. These individuals will be excluded because this may require additional medical monitoring and adjustments to the exercise prescription. - Report taking any type of medication that could affect metabolism, energy intake or change body weight (e.g., hypothyroidism). - Report hospitalization for psychiatric problems prior year to the enrollment period. - If they are on a regime to increase muscle mass or taking anabolics - Excessive consumption of alcoholic beverages, defined as 21 or more drinks per week |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Mexico | National Institute of Public Health | Cuernavaca | Morelos |
Lead Sponsor | Collaborator |
---|---|
Mexican National Institute of Public Health | Danone Research, University of North Carolina, Chapel Hill |
Mexico,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Triglycerides blood level | baseline | No | |
Primary | Triglycerides blood levels | 3 months | No | |
Primary | Triglycerides blood Levels | 6 months | No | |
Primary | Triglycerides blood levels | 9 months | No | |
Secondary | Body weight | Baseline | No | |
Secondary | Fasting insulin | Baseline | No | |
Secondary | Fasting glucose | Baseline | No | |
Secondary | Homeostasis Model Assessment (HOMA) | Baseline | No | |
Secondary | HDL-cholesterol | Baseline | No | |
Secondary | Systolic and diastolic blood pressure | Baseline | No | |
Secondary | Waist circumference | Baseline | No | |
Secondary | Glycosylated (or glycated) hemoglobin (HbA1c) | Baseline | No | |
Secondary | Boby Weight | 3 months | No | |
Secondary | Body weight | 6 months | No | |
Secondary | Body weight | 9 months | No | |
Secondary | Fasting insulin | 3 months | No | |
Secondary | Fasting insulin | 6 months | No | |
Secondary | Fasting insulin | 9 months | No | |
Secondary | Fasting glucose | 3 months | No | |
Secondary | Fasting glucose | 6 months | No | |
Secondary | Fasting glucose | 9 months | No | |
Secondary | Homeostasis Model Assessment (HOMA) | 3 months | No | |
Secondary | Homeostasis Model Assessment (HOMA) | 6 months | No | |
Secondary | Homeostasis Model Assessment (HOMA) | 9 months | No | |
Secondary | HDL-cholesterol | 3 months | No | |
Secondary | HDL-cholesterol | 6 months | No | |
Secondary | HDL-cholesterol | 9 months | No | |
Secondary | Systolic and diastolic blood pressure | 3 months | No | |
Secondary | Systolic and diastolic blood pressure | 6 months | No | |
Secondary | Systolic and diastolic blood pressure | 9 months | No | |
Secondary | Waist circumference | 3 months | No | |
Secondary | Waist circumference | 6 months | No | |
Secondary | Waist circumference | 9 months | No | |
Secondary | Glycosylated (or glycated) hemoglobin (HbA1c) | 9 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04635202 -
Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome
|
N/A | |
Completed |
NCT04053686 -
An Intervention to Reduce Prolonged Sitting in Police Staff
|
N/A | |
Completed |
NCT05343858 -
Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Recruiting |
NCT05040958 -
Carotid Atherosclerotic Plaque Load and Neck Circumference
|
||
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Active, not recruiting |
NCT02500147 -
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
|
Phase 4 | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Completed |
NCT03289897 -
Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan
|
N/A | |
Recruiting |
NCT05956886 -
Sleep Chatbot Intervention for Emerging Black/African American Adults
|
N/A | |
Completed |
NCT06057896 -
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
|
||
Active, not recruiting |
NCT03613740 -
Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
|
Phase 2 | |
Completed |
NCT04498455 -
Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency
|
Phase 4 | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT03697382 -
Effect of Daily Steps on Fat Metabolism
|
N/A | |
Completed |
NCT03241121 -
Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome
|
N/A | |
Completed |
NCT04509206 -
Virtual Teaching Kitchen
|
N/A | |
Completed |
NCT05124847 -
TREating Pediatric Obesity
|
N/A |